CEPI – Valneva, Chikungunya Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 24, 2021 Post category: Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement
Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement Post author:GHIAA Editor Post published:July 1, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement
NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingNIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
Gates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingGates Foundation – CureVac – GSK, Letter Agreement for Alignment on Global Access Commitments
US Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement Post author:GHIAA Admin Post published:June 30, 2021 Post category: Continue ReadingUS Government – Ology Bioservices, COVID-19 Plasmid Procurement Agreement
CEPI – CureVac, Framework Partnering Agreement Post author:GHIAA Editor Post published:June 30, 2021 Post category: Continue ReadingCEPI – CureVac, Framework Partnering Agreement
CEPI – Novavax, COVID-19 Vaccine Funding Agreement Post author:GHIAA Editor Post published:May 14, 2021 Post category: Continue ReadingCEPI – Novavax, COVID-19 Vaccine Funding Agreement
US Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement Post author:GHIAA Admin Post published:April 16, 2021 Post category: Continue ReadingUS Army Contracting Command (via ATI) – Regeneron, COVID-19 Antibodies Large-Scale Manufacturing Agreement
US Department of Defense – Novavax, COVID-19 Vaccine Development Agreement Post author:GHIAA Admin Post published:March 23, 2021 Post category: Continue ReadingUS Department of Defense – Novavax, COVID-19 Vaccine Development Agreement